Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45,267 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Comparison of 2 Disease Burden Assessment Methods (3D Volume Versus the Number of Lesions) for Prognostication of Survival in Metastatic Melanoma: Implications for the Characterization of Oligometastatic Disease.
Kim J, Chang JS, Sung W, Kim JS, Kim TH, Choi SH, Kim KH, Ko H, Lee HS, Jeon S, Shin SJ, Liu M, Olson R. Kim J, et al. Among authors: liu m. Int J Radiat Oncol Biol Phys. 2022 Dec 1;114(5):883-891. doi: 10.1016/j.ijrobp.2022.08.040. Epub 2022 Aug 23. Int J Radiat Oncol Biol Phys. 2022. PMID: 36007725
Hemoglobin levels do not predict biochemical outcome for localized prostate cancer treated with neoadjuvant androgen-suppression therapy and external-beam radiotherapy.
Pai HH, Ludgate C, Pickles T, Paltiel C, Agranovich A, Berthelet E, Duncan G, Kim-Sing C, Kwan W, Lim J, Liu M, Tyldesley S. Pai HH, et al. Among authors: liu m. Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):990-8. doi: 10.1016/j.ijrobp.2006.02.008. Epub 2006 May 6. Int J Radiat Oncol Biol Phys. 2006. PMID: 16682135
Evaluation of dosimetric parameters and disease response after 125 iodine transperineal brachytherapy for low- and intermediate-risk prostate cancer.
Morris WJ, Keyes M, Palma D, McKenzie M, Spadinger I, Agranovich A, Pickles T, Liu M, Kwan W, Wu J, Lapointe V, Berthelet E, Pai H, Harrison R, Kwa W, Bucci J, Racz V, Woods R. Morris WJ, et al. Among authors: liu m. Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1432-8. doi: 10.1016/j.ijrobp.2008.07.042. Epub 2008 Nov 25. Int J Radiat Oncol Biol Phys. 2009. PMID: 19036530
Biochemical control with radiotherapy improves overall survival in intermediate and high-risk prostate cancer patients who have an estimated 10-year overall survival of >90%.
Herbert C, Liu M, Tyldesley S, Morris WJ, Joffres M, Khaira M, Kwan W, Moiseenko V, Pickles T. Herbert C, et al. Among authors: liu m. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):22-7. doi: 10.1016/j.ijrobp.2011.05.076. Epub 2011 Nov 11. Int J Radiat Oncol Biol Phys. 2012. PMID: 22079724
Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial.
Palma DA, Haasbeek CJ, Rodrigues GB, Dahele M, Lock M, Yaremko B, Olson R, Liu M, Panarotto J, Griffioen GH, Gaede S, Slotman B, Senan S. Palma DA, et al. Among authors: liu m. BMC Cancer. 2012 Jul 23;12:305. doi: 10.1186/1471-2407-12-305. BMC Cancer. 2012. PMID: 22823994 Free PMC article. Clinical Trial.
45,267 results
You have reached the last available page of results. Please see the User Guide for more information.